UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.643-649

2017

Volltextzugriff (PDF)

Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists

Annals of the rheumatic diseases, 2010-10, Vol.69 (10), p.1751-1755

2010

Volltextzugriff (PDF)

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.382-385

2012

Volltextzugriff (PDF)

Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists

Seminars in arthritis and rheumatism, 2011-08, Vol.41 (1), p.71-80

2011

Volltextzugriff (PDF)

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

Seminars in arthritis and rheumatism, 2012-08, Vol.42 (1), p.89-103

2012

Volltextzugriff (PDF)

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

Rheumatology (Oxford, England), 2011-11, Vol.50 (11), p.1999-2004

2011

Volltextzugriff (PDF)

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

Seminars in arthritis and rheumatism, 2011-02, Vol.40 (4), p.330-337

2011

Volltextzugriff (PDF)

Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0

Rheumatology (Oxford, England), 2011-01, Vol.50 (1), p.85-92

2011

Volltextzugriff (PDF)

The Spanish version of the FibroFatigue Scale: validation of a questionnaire for the observer's assessment of fibromyalgia and chronic fatigue syndrome

General hospital psychiatry, 2006-03, Vol.28 (2), p.154-160

2006

Volltextzugriff (PDF)

Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment

Medicina clínica, 2008-10, Vol.131 (13), p.493-499

2008

Volltextzugriff (PDF)

Efficacy of Sphincter Control Training and medical device in the treatment of premature ejaculation: A multicenter randomized controlled clinical trial

PloS one, 2021-09, Vol.16 (9), p.e0257284-e0257284

2021

Volltextzugriff (PDF)

Prostate carcinogenesis: inflammatory storms

Nature reviews. Cancer, 2020-08, Vol.20 (8), p.455-469

2020

Volltextzugriff (PDF)

Efficacy of Sphincter Control Training (SCT) in the treatment of premature ejaculation, a new cognitive behavioral approach: A parallel-group randomized, controlled trial

PloS one, 2019-02, Vol.14 (2), p.e0212274-e0212274

2019

Volltextzugriff (PDF)

An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy

Multiple sclerosis, 2016-05, Vol.22 (6), p.842-846

2016

Volltextzugriff (PDF)

Treatment preferences as basis for decision making in patients using direct oral anticoagulants in Spain

Journal of thrombosis and thrombolysis, 2021-02, Vol.51 (2), p.475-484

2021

Volltextzugriff (PDF)

Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

Annals of the rheumatic diseases, 2024-07, Vol.83 (7), p.847-857

2024

Volltextzugriff (PDF)

Bacteremia in previously healthy children in Emergency Departments: clinical and microbiological characteristics and outcome

European journal of clinical microbiology & infectious diseases, 2015-03, Vol.34 (3), p.453-460

2015

Volltextzugriff (PDF)

Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study

Neurologia (Barcelona, Spain), 2015-05, Vol.30 (4), p.214

2015

Volltextzugriff (PDF)

Eating Habits, Physical Activity, Consumption of Substances and Eating Disorders in Adolescents

The Spanish journal of psychology, 2011-11, Vol.14 (2), p.712-723

2011

Volltextzugriff (PDF)

Management of Rheumatoid Arthritis in Spain (emAR II). Clinical Characteristics of the Patients

Reumatologia clinica, 2012-09, Vol.8 (5), p.236-242

2012

Volltextzugriff (PDF)

Characteristics of patients with spondyloarthritis followed in rheumatology units in Spain. emAR II study

Reumatologia clinica, 2012-05, Vol.8 (3), p.107

2012

Volltextzugriff (PDF)

The Social Tariff of EQ-5D Is Not Adequate to Assess Quality of Life in Patients with Low Back Pain

Quality of life research, 2007-04, Vol.16 (3), p.523-531

2007

Volltextzugriff (PDF)

Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study

Reumatologia clinica, 2012-05, Vol.8 (3), p.114

2012

Volltextzugriff (PDF)

Appropriateness of colonoscopy requests according to EPAGE-II in the Spanish region of Catalonia

BMC family practice, 2015-10, Vol.16 (1), p.154, Article 154

2015

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(23)
Spanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0

Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0

The Spanish version of the FibroFatigue Scale: validation of a questionnaire for the observer's assessment of fibromyalgia and chronic fatigue syndrome

Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment

Efficacy of Sphincter Control Training and medical device in the treatment of premature ejaculation: A multicenter randomized controlled clinical trial

Prostate carcinogenesis: inflammatory storms

Efficacy of Sphincter Control Training (SCT) in the treatment of premature ejaculation, a new cognitive behavioral approach: A parallel-group randomized, controlled trial

An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy

Treatment preferences as basis for decision making in patients using direct oral anticoagulants in Spain

Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

Bacteremia in previously healthy children in Emergency Departments: clinical and microbiological characteristics and outcome

Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study

Eating Habits, Physical Activity, Consumption of Substances and Eating Disorders in Adolescents

Management of Rheumatoid Arthritis in Spain (emAR II). Clinical Characteristics of the Patients

Characteristics of patients with spondyloarthritis followed in rheumatology units in Spain. emAR II study

The Social Tariff of EQ-5D Is Not Adequate to Assess Quality of Life in Patients with Low Back Pain

Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study

Appropriateness of colonoscopy requests according to EPAGE-II in the Spanish region of Catalonia

Aktive Filter

Suchergebnisse filtern